fda shortage semaglutide injection products resolved feb 21 2025 Novo Nordisk's officially concludes in the US, spelling major threat for weight loss drug compounders Compounded Semaglutide & Tirzepatide 2025:

A key factor is cost, as Ozempic can be expensive, particularly without insurance coverage

From GLP-1s to longevity and new views on self-care for healthcare, the people are taking their health in-hand, at-home, and via-tech to complement and sometimes replace the legacy health system touchpoints which are the traditional categories for care: hospitals, doctors, rehab centers, diagnostics and labs, and health care financing and plans some opting out of plans and going full-risk (cash, out-of-pocket) truly self-insuring against future medical risks

But factors like aging, pollution, stress, and poor diet can deplete its levels

AI-Discovered Drugs in Clinical Trials 2026: Full Pipeline A data-driven 2026 survey of AI-discovered drugs in clinical trials, mapping Insilico Medicine, Recursion Pharmaceuticals, Isomorphic Labs, success rates, funding, and named case studies.

Shirasaka, Y